1 Product identity

Ingredient risk

1 ingredient to use with caution

Serraflazyme

Name: Serraflazyme
Brand: Cardiovascular Research

BrandCardiovascular Research→Non-Nutrient/Non-Botanical Tablet or Pill 12 ingredients 1 caution DSLD #22999

Net contents: 100 Tablet(s)

Target: Adults and Children 4 years and above

DSLD entry: 2013-06-25

2 Ingredients (12)

IngredientGroupSafety

SerrapeptaseSerratiopeptidase—

Microcrystalline CelluloseCellulose—

Calcium PhosphateCalciumConditionally Safe

Hydroxypropyl MethylcelluloseHypromellose—

Silicon DioxideSiliconGenerally Safe

Magnesium StearateMagnesium stearateUse with Caution

Sodium AlginateSodiumConditionally Safe

Stearic AcidStearic Acid—

EthylcelluloseEthylcellulose—

Ammonium HydroxideAmmonia—

Medium Chain TriglyceridesMedium chain triglycerides (MCT)—

Oleic AcidOleic Acid—

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

⚠️ Use with caution — restricted in some markets

Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].

3 Safety cross-reference

Serrapeptase — Limited Evidence

⚠ Increased bleeding risk

⚠ Lung inflammation (rare)

Calcium — Conditionally Safe

⚠ Cardiovascular risk debated >1,000 mg/day

⚠ Kidney stones

Silicon — Generally Safe

⚠ Very low toxicity

Magnesium — Use with Caution

⚠ Diarrhea (especially oxide)

⚠ Accumulates in renal impairment

Sodium — Conditionally Safe

⚠ Hypertension

⚠ Fluid retention

4 Label claims

• All Other

• Structure/Function

5 Data source

DSLD ID22999

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2013-06-25

6 More from Cardiovascular Research

View Cardiovascular Research Safety Scorecard → 58 products

A Plus Oil-Free Vitamin A And Beta Carotene Abdominal Lean ALC - 1000 Betarutin Black Currant Seed Oil GLA ALA Bladder Up

7 Cite this page

Vancouver

Pkhakadze G. Serraflazyme — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 30]. Available from: https://supplement.ge/products/serraflazyme-22999/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG